A Study to Investigate Efficacy and Safety of a TCA108 in Participants ≥18 Years With Uncontrolled Hypertension
NCT07030101 · Status: NOT_YET_RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 400
Last updated 2025-11-24
Summary
The purpose of this study if to evaluate the efficacy and safety of TCA108 in the treatment of hypertension.
Conditions
Interventions
- DRUG
-
TCA108
TCA108
- DRUG
-
Bramicar HCT
Bramicar HCT
- DRUG
-
Micardis Anlo
Micardis Anlo
Sponsors & Collaborators
-
EMS
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-11-30
- Primary Completion
- 2029-05-31
- Completion
- 2029-11-30
More Related Trials
-
To Evaluate Real-world Safety, Effectiveness and Appropriate Use of Micatrio® Combination Tablets Treatment in Patients With Hypertension
NCT03021265 ·Status: COMPLETED
-
Micardis® in Patients With Essential Hypertension
NCT02187705 ·Status: COMPLETED
-
Hypertension Study: Multinational Torasemide Trial in Mild to Moderate Hypertension.
NCT00334386 ·Status: COMPLETED ·Phase: PHASE4
-
Trial of Telmisartan 80 mg/HCTZ 12.5 mg and Telmisartan 40 mg/HCTZ 12.5 mg in Patients With Hypertension
NCT00326768 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Safety and Efficacy in MK-0954A Combination in Participants With Hypertension (MK-0954A-373 AM3)
NCT01431508 ·Status: COMPLETED ·Phase: PHASE4
-
Compare Efficacy and Safety of Telmisartan/Hydrochlorothiazide With Telmisartan/Hydrochlorothiazide Plus Amlodipine
NCT01911780 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate the Efficacy and Safety of Combined Administration of TAK-536CCB and Hydrochlorothiazide in Patients With Grade I or II Essential Hypertension.
NCT02072330 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Survey to Assess Why People Are Not Responding to Treatment in Hypertension
NCT01071681 ·Status: COMPLETED
-
A Study to Evaluate the Safety of QCZ484 in Healthy and Mild Hypertensive Subjects
NCT06905327 ·Status: COMPLETED ·Phase: PHASE1
-
A Long-term Study of the Safety of MK-0954A in Patients With Essential Hypertension (MK-0954A-351)
NCT01307033 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Investigate the Magnitude and Duration of Response of MK0954 Compared to Placebo in Patients With Hypertension (0954-021)(COMPLETED)
NCT00886600 ·Status: COMPLETED ·Phase: PHASE3
-
To Determine Blood Pressure Interaction Between TC-5214 and Anti-Hypertensive Medications (Calcium Channel Blockers, Beta Blockers, and ACE Inhibitors) in Patients With Chronic Hypertension
NCT01403922 ·Status: TERMINATED ·Phase: PHASE1
-
Optimal Medical Treatment of Difficult-to-treat Hypertension
NCT06275763 ·Status: RECRUITING ·Phase: PHASE4
-
Effectiveness and Safety of Ramipril Alone Compared With Telmisartan Alone and in Combination With Ramipril in Patients at High Risk for Cardiovascular Events. Patients Intolerant to Ramipril Were Entered in TRANSCEND, Telmisartan Compared to Placebo.
NCT00153101 ·Status: COMPLETED ·Phase: PHASE4
-
Dose-ranging Study to Evaluate the Effectiveness and Tolerability of MK0736 in Patients With Type 2 Diabetes Mellitus (T2DM) and Hypertension (0736-007)
NCT00806585 ·Status: TERMINATED ·Phase: PHASE2
-
Hypertensive Ambulatory Trial to Compare the Efficacy of HCTZ and Lisinopril
NCT01258764 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate ART101 in Adult Participants With Hypertension
NCT06780033 ·Status: TERMINATED ·Phase: PHASE1
-
VB19055 Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study in a Healthy Chinese Population
NCT07254481 ·Status: RECRUITING ·Phase: PHASE1
-
MK-0954E Phase III Long-Term Study in Participants With Hypertension (MK-0954E-356)
NCT01299376 ·Status: COMPLETED ·Phase: PHASE3
-
Investigator Initiated Randomized Open-label Comparative Study of Britomar (Prolonged Release Torasemide) and Diuver (Torasemide) to Assess Effects on Natriuresis and Central Hemodynamics.
NCT02087332 ·Status: UNKNOWN ·Phase: PHASE4
-
Irbesartan/Hydrochlorothiazide (HCTZ) Combination Therapy as First Line Treatment for Severe Hypertension
NCT00095394 ·Status: COMPLETED ·Phase: PHASE3
-
3 x 3 Factorial Trial of Telmisartan and Hydrochlorothiazide in Patients With Essential Hypertension
NCT00153049 ·Status: COMPLETED ·Phase: PHASE2
-
Ramipril and Hydrochlorothiazide Alone and in Combination for the Treatment of Essential Hypertension
NCT00355589 ·Status: COMPLETED ·Phase: PHASE3
-
Imatinib (QTI571) in Pulmonary Arterial Hypertension
NCT00902174 ·Status: COMPLETED ·Phase: PHASE3
-
Avoiding Cardiovascular Events Through Combination Therapy in Patients Living With Systolic Hypertension
NCT00170950 ·Status: TERMINATED ·Phase: PHASE3